| 0 | 💬 0 |
Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trial.
(linkinghub.elsevier.com)
|
Lancet Infectious Diseases 2026-04-28 | #vaccination #immunogenicity #safety #rabies #adenovirus |